Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR+23.1%
5Y CAGR-22.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+23.1%/yr
vs -16.7%/yr prior
5Y CAGR
-22.9%/yr
Recent acceleration
Acceleration
+39.7pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.65M | +11.0% |
| 2024 | $25.80M | -10.0% |
| 2023 | $28.68M | +86.7% |
| 2022 | $15.36M | -83.0% |
| 2021 | $90.54M | -13.9% |
| 2020 | $105.14M | +46.2% |
| 2019 | $71.90M | +125.8% |
| 2018 | $31.84M | -78.0% |
| 2017 | $144.58M | +977.9% |
| 2016 | $13.41M | - |